Dano Pharmaceuticals was incorporated in 2013. It is a biotechnology company near commercialization that focuses on discovering, developing and commercializing differentiated innovative drug products to address unmet clinical needs in the fields of bacterial infections and bacterial metabolization-related diseases. With its self-developed multi-target coupled molecular technology, Danno is committed to providing patient